In addition, the serum levels of irisin and adropin in patients with DM type 2 were identified to be connected to the change in metabolic factors [32, 33], such as insulin resistance index [34] and endothelium dysfunction [35–37]. This evidence concerns the gene ENHO and Insulin resistance.